Clin2
NCT03362164Possibly a fitRecruiting

Studying heart involvement in people with Fabry disease

Rare DiseasesFabry DiseaseFabry Disease, Cardiac VariantHypertrophic Cardiomyopathy

Part of Brain & nervous system, Genetic & congenital, Heart & circulation, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.

This study looks at how the heart is affected in adults with Fabry disease. It may help doctors better understand heart-related changes in order to guide care.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
650 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have genetically confirmed Fabry disease
  • You are 18 years old or older
  • You can sign and give informed consent to join the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06512571Recruiting
Heart changes in Fabry disease: an observational study

This study looks at people with Fabry disease, a genetic condition that can cause the heart muscle to thicken. Researchers want to understand how the heart's blood vessels change over time, which may help improve care for Fabry disease.

Beijing
NCT06806813Recruiting
Italian Fabry disease heart registry

This study is creating a registry of people with Fabry disease to better understand how it affects the heart. By joining, you help doctors learn more about the condition and improve care for future patients.

Chieti, Abruzzo/Chieti
NCT04856059Recruiting
MRI study for early heart changes in Fabry disease

This study looks at early structural and tissue changes in the heart using a special type of MRI scan in adults with Fabry disease. It may help doctors understand changes earlier and better track heart involvement over time.

Toronto, Ontario
NCT07235709Recruiting
Study of agalsidase alfa for heart inflammation in Fabry disease

This trial tests whether agalsidase alfa can reduce heart inflammation in people with Fabry disease who have heart problems. You may qualify if you have not had this treatment in the past year.

Seoul
NCT06776419Recruiting
Heart inflammation and scarring in Fabry disease

This study uses advanced heart scans (PET/CT and MRI) to look at inflammation, blood vessel health, and scarring in the hearts of people with Fabry disease. It aims to better understand how Fabry disease affects the heart and find new ways to track or treat these changes.

Copenhagen
NCT05698901Recruiting
Testing heart blood tests and scans to monitor Fabry disease

This study checks whether certain heart-related blood tests and heart scans can help monitor people with Fabry disease. It may be useful for both people who have never received enzyme replacement therapy and those who have.

Taipei

Hear when a new Rare Diseases trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.